Barclays PLC Inovio Pharmaceuticals, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023
SELL
$0.39 - $0.94 $309,686 - $746,422
-794,067 Reduced 92.46%
64,715 $29,000
Q1 2023

May 04, 2023
SELL
$0.79 - $1.91 $390,917 - $945,129
-494,832 Reduced 36.56%
858,782 $705,000
Q4 2022

Feb 13, 2023
BUY
$1.41 - $2.5 $277,957 - $492,832
197,133 Added 17.05%
1,353,614 $2.11 Million
Q3 2022

Nov 03, 2022
BUY
$1.66 - $2.79 $1.9 Million - $3.2 Million
1,145,448 Added 10382.02%
1,156,481 $2 Million
Q2 2022

Aug 12, 2022
SELL
$1.44 - $3.98 $35,068 - $96,924
-24,353 Reduced 68.82%
11,033 $19,000
Q1 2022

May 16, 2022
SELL
$2.97 - $5.2 $640,281 - $1.12 Million
-215,583 Reduced 85.9%
35,386 $126,000
Q4 2021

Feb 14, 2022
BUY
$4.99 - $7.46 $826,733 - $1.24 Million
165,678 Added 194.25%
250,969 $1.25 Million
Q3 2021

Nov 09, 2021
BUY
$7.16 - $9.69 $316,708 - $428,617
44,233 Added 107.73%
85,291 $611,000
Q2 2021

Aug 13, 2021
SELL
$6.23 - $10.03 $716,250 - $1.15 Million
-114,968 Reduced 73.69%
41,058 $380,000
Q1 2021

May 13, 2021
SELL
$8.81 - $16.96 $414,554 - $798,052
-47,055 Reduced 23.17%
156,026 $1.45 Million
Q4 2020

Feb 11, 2021
SELL
$8.5 - $12.85 $391,008 - $591,112
-46,001 Reduced 18.47%
203,081 $1.8 Million
Q3 2020

Nov 12, 2020
SELL
$9.57 - $27.05 $108,074 - $305,475
-11,293 Reduced 4.34%
249,082 $2.89 Million
Q2 2020

Aug 12, 2020
BUY
$7.14 - $31.69 $480,850 - $2.13 Million
67,346 Added 34.89%
260,375 $7.02 Million
Q1 2020

May 13, 2020
BUY
$2.98 - $14.09 $298,736 - $1.41 Million
100,247 Added 108.05%
193,029 $1.44 Million
Q4 2019

Feb 10, 2020
BUY
$1.97 - $3.72 $68,908 - $130,121
34,979 Added 60.51%
92,782 $306,000
Q3 2019

Nov 14, 2019
SELL
$2.05 - $3.02 $15,666 - $23,078
-7,642 Reduced 11.68%
57,803 $119,000
Q2 2019

Aug 14, 2019
BUY
$2.29 - $4.1 $93,619 - $167,616
40,882 Added 166.44%
65,445 $192,000
Q1 2019

May 15, 2019
SELL
$3.34 - $5.1 $156,699 - $239,271
-46,916 Reduced 65.64%
24,563 $92,000
Q4 2018

Feb 14, 2019
SELL
$3.89 - $6.11 $21,857 - $34,332
-5,619 Reduced 7.29%
71,479 $286,000
Q3 2018

Nov 14, 2018
BUY
$3.92 - $5.58 $260,005 - $370,110
66,328 Added 615.86%
77,098 $429,000
Q2 2018

Aug 14, 2018
SELL
$3.88 - $5.16 $61,141 - $81,311
-15,758 Reduced 59.4%
10,770 $42,000
Q1 2018

May 15, 2018
SELL
$4.05 - $5.69 $212,770 - $298,929
-52,536 Reduced 66.45%
26,528 $125,000
Q4 2017

Feb 14, 2018
BUY
$4.13 - $6.68 $239,688 - $387,680
58,036 Added 275.99%
79,064 $326,000
Q3 2017

Nov 14, 2017
BUY
$5.36 - $6.37 $112,710 - $133,948
21,028
21,028 $134,000

Others Institutions Holding INO

# of Institutions
10
Shares Held
281K
Call Options Held
0
Put Options Held
0
View Full List

About INOVIO PHARMACEUTICALS, INC.

INO Quotes by TradingView
  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $566M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email